| Ms Karen Lynn Johnson, RNFA | |
|
548 W Shore Trl, Sparta, NJ 07871-1434 | |
| (973) 729-6377 | |
| Not Available |
| Full Name | Ms Karen Lynn Johnson |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Registered Nurse First Assistant |
| Location | 548 W Shore Trl, Sparta, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689824773 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WR0006X | Registered Nurse - Registered Nurse First Assistant | 26NR06777000 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Karen Lynn Johnson, RNFA 548 W Shore Trl, Sparta, NJ 07871-1434 Ph: (973) 729-6377 | Ms Karen Lynn Johnson, RNFA 548 W Shore Trl, Sparta, NJ 07871-1434 Ph: (973) 729-6377 |
News Archive
Calypso Medical Technologies, Inc., a developer of targeting technology used for accurate, precise real-time tracking of tumor targets, today announced the online publication of a clinical study in Urology (The GOLD JOURNAL). The prospective, multi-site study, entitled, "Assessing the Impact of Margin Reduction (AIM)," is the first outcomes-based study to evaluate the quality of life of high-dose intensity-modulated radiotherapy (IMRT) to the prostate with tightly contoured treatment technically described as "reduced treatment margins."
Celgene International Sàrl, a subsidiary of Celgene Corporation today presented results from a randomized, placebo-controlled phase II trial in patients with Behçet's disease at EULAR, the European Congress of Rheumatology annual meeting in Madrid.
Lakewood-Amedex, a leading developer of novel anti-infective pharmaceuticals, announced today that the United States Patent and Trademark Office has issued Notice of Allowances on three patent applications relating to the use of novel monoclonal antibodies for the treatment of hemolytic uremic syndrome caused by shiga toxin II secreting E.coli O157: H7 strain.
A team from the George Washington University Cancer Center has engineered a nanoimmunotherapy that combines the advantages of nanotechnology and immunotherapy to treat cancer.
New findings by researchers at UT Southwestern Medical Center suggest that serotonin a brain chemical known to help regulate emotion, mood and sleep might also have anti-diabetic properties.
› Verified 9 days ago
Fiorella Paradisi, Registered Nurse Medicare: May Accept Medicare Assignments Practice Location: 17 Davis Rd, Sparta, NJ 07871 Phone: 201-727-3241 | |
Katherine A Member, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 514 Lafayette Rd Ste D, Sparta, NJ 07871 Phone: 973-940-2400 Fax: 973-940-0138 | |
Nicholas W Tinker, FNP-BC Registered Nurse Medicare: Medicare Enrolled Practice Location: 89 Sparta Ave, Sparta, NJ 07871 Phone: 973-729-2121 | |
Marianna Lundberg, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 81 Cheyenne Trl, Sparta, NJ 07871 Phone: 201-317-7414 | |
Mrs. Crystal Bawuah, RN, DON Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 9 Benham Way, Sparta, NJ 07871 Phone: 908-342-6330 | |
Margaret Schanbacher, RN,BSN,CCM Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 25 Oak Tree Ln, Sparta, NJ 07871 Phone: 973-670-3403 Fax: 484-727-4739 |